The efficacy of a single dose of infliximab in the treatment of Behçet's disease uveitis.
Arayssi
T
T
Hamra
R
R
Homeidan
F
F
Uthman
I
I
Awwad
S T
ST
Mroue
K
K
Mansour
W
W
Bashshur
Z F
ZF
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000150:complications / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D000069285:Infliximab; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D016896:Treatment Outcome; D014606:Uveitis, Anterior / Q000188:drug therapy* / Q000209:etiology; D015866:Uveitis, Posterior / Q000188:drug therapy* / Q000209:etiology; D014822:Vitreous Body / Q000187:drug effects / Q000503:physiopathology
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab; D011241:Prednisone